Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Celeghini

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The American Journal of Pathology|November 30, 2005
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cellsPaola Secchiero, Elisa Barbarotto, Arianna Gonelli, et al.
Haematologica|June 13, 2012
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 statusGiorgio Zauli, Claudio Celeghini, Elisabetta Melloni, et al.
International Journal of Molecular Sciences|May 23, 2018
Neuronal Dysfunction Associated with Cholesterol DeregulationAnnalisa Marcuzzi, Claudia Loganes, Erica Valencic, et al.
Oncotarget|June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.
Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.
Journal of Medicinal Chemistry|December 15, 2015
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic ActivityClaudio Trapella, Rebecca Voltan, Elisabetta Melloni, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological InhibitorsErika Rimondi, Elisabetta Melloni, Arianna Romani, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 27, 2016
Complement component C1q as potential diagnostic but not predictive marker of preeclampsiaChiara Agostinis, Tamara Stampalija, Dionne Tannetta, et al.
Experimental Hematology|October 27, 2004
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesisBianca Rocca, Paola Secchiero, Claudio Celeghini, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Pathology|November 30, 2005
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cellsPaola Secchiero, Elisa Barbarotto, Arianna Gonelli, et al.
Haematologica|June 13, 2012
The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 statusGiorgio Zauli, Claudio Celeghini, Elisabetta Melloni, et al.
International Journal of Molecular Sciences|May 23, 2018
Neuronal Dysfunction Associated with Cholesterol DeregulationAnnalisa Marcuzzi, Claudia Loganes, Erica Valencic, et al.
Oncotarget|June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.
Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.
Journal of Medicinal Chemistry|December 15, 2015
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic ActivityClaudio Trapella, Rebecca Voltan, Elisabetta Melloni, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological InhibitorsErika Rimondi, Elisabetta Melloni, Arianna Romani, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 27, 2016
Complement component C1q as potential diagnostic but not predictive marker of preeclampsiaChiara Agostinis, Tamara Stampalija, Dionne Tannetta, et al.
Experimental Hematology|October 27, 2004
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesisBianca Rocca, Paola Secchiero, Claudio Celeghini, et al.
Pageof 6